USPTO Examiner MAPAR BIJAN - Art Unit 2148

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18442107COUPLING NUMERICAL SIMULATION METHOD FOR SITE SELECTION OF UNDERGROUND SALT CAVERN HYDROGEN STORAGEFebruary 2024August 2024Allow610NoNo
18402831METHOD AND DEVICE FOR FAULT ESTIMATION OF MEASUREMENT AND CONTROL DEVICE FOR ROTARY STEERABLE DRILLING SYSTEMJanuary 2024June 2024Allow610NoNo
18216345Surface Modified Unit Cell Lattice Structures For Optimized Secure Freeform FabricationJune 2023May 2024Allow1110NoNo
18209702SYSTEMS AND METHODS FOR INTERACTIVE DISPLAY OF SYMBOLIC EQUATIONS EXTRACTED FROM GRAPHICAL MODELSJune 2023April 2024Allow1110YesNo
18320746SYSTEMS FOR USING RESCAN DATA FOR DENTAL PROCEDURESMay 2023April 2024Allow1010YesNo
18297216SYSTEMS AND METHODS FOR DESCRIBING, SIMULATING AND OPTIMIZING SPACEBORNE SYSTEMS AND MISSIONSApril 2023February 2024Allow1010NoNo
17426551SYSTEMS AND METHODS FOR INTEGRATED AND COMPREHENSIVE HYDRAULIC, THERMAL AND MECHANICAL TUBULAR DESIGN ANALYSIS FOR COMPLEX WELL TRAJECTORIESJuly 2021June 2024Allow3410YesNo
17422099METHOD FOR SIMULATING CHATTER-FREE MILLED SURFACE TOPOGRAPHYJuly 2021November 2024Abandon4010NoNo
17339310ASSESSING INTRA-CARDIAC ACTIVATION PATTERNSJune 2021June 2024Allow3740YesNo
17288577DATA PROCESSING APPARATUS, DATA PROCESSING SYSTEM, AND DATA PROCESSING METHODApril 2021September 2024Abandon4110NoNo
17188261METHOD MAKING IT POSSIBLE TO PRODUCE THE IDEAL CURVATURE OF A ROD OF VERTEBRAL OSTEOSYNTHESIS MATERIAL DESIGNED TO SUPPORT A PATIENT'S VERTEBRAL COLUMNMarch 2021January 2024Allow3510NoNo
17267389Geometrical Compensations for Additive ManufacturingFebruary 2021February 2024Allow3710NoNo
17157144METHOD AND DEVICE FOR CREATING A MODEL OF A TECHNICAL SYSTEM FROM MEASUREMENTSJanuary 2021March 2024Allow3820YesNo
17139294SIMULATION SIGNAL VIEWING METHOD AND SYSTEM FOR DIGITAL PRODUCTDecember 2020May 2024Abandon4120NoNo
17131905COMPUTER SIMULATION OF HUMAN RESPIRATORY DROPLETSDecember 2020July 2024Allow4240YesNo
17081964IMAGING DEVICE AND METHOD OF OPERATING THE SAMEOctober 2020April 2024Allow4110NoNo
17031556SYSTEM AND METHOD FOR PROVIDING VISUAL GUIDANCE IN A MEDICAL SURGERYSeptember 2020February 2024Allow4110NoNo
17010944Systems and Methods to Measure Quantum Gate Fidelity through Swap SpectroscopySeptember 2020March 2024Allow4210NoNo
16898710METHOD AND APPARATUS FOR GENERATING MOTION OF OBJECTJune 2020June 2024Allow4820NoNo
16881828STRUCTURAL ANALYTICAL BUILDING MODEL APPARATUS AND METHODMay 2020June 2024Abandon4950YesNo
16641471METHOD OF OPTIMIZATION IN ORTHODONTIC APPLICATIONSFebruary 2020July 2024Abandon5320NoNo
16731020DETERMINATION OF STRUCTURAL CHARACTERISTICS OF AN OBJECTDecember 2019May 2024Allow5220NoNo
16330191SYSTEM AND METHOD FOR MODELING CHARACTERISTICS OF A MELT POOL THAT FORMS DURING AN ADDITIVE MANUFACTURING PROCESSMarch 2019May 2024Abandon6020NoYes
15863767TECHNIQUES FOR DESIGNING INTERACTIVE OBJECTS WITH INTEGRATED SMART DEVICESJanuary 2018February 2024Allow6080YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MAPAR, BIJAN.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
4.4%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
1
(100.0%)
Filing Benefit Percentile
2.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner MAPAR, BIJAN - Prosecution Strategy Guide

Executive Summary

Examiner MAPAR, BIJAN works in Art Unit 2148 and has examined 18 patent applications in our dataset. With an allowance rate of 66.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 41 months.

Allowance Patterns

Examiner MAPAR, BIJAN's allowance rate of 66.7% places them in the 28% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by MAPAR, BIJAN receive 2.28 office actions before reaching final disposition. This places the examiner in the 64% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by MAPAR, BIJAN is 41 months. This places the examiner in the 21% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +25.0% benefit to allowance rate for applications examined by MAPAR, BIJAN. This interview benefit is in the 72% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.0% of applications are subsequently allowed. This success rate is in the 11% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 25.0% of cases where such amendments are filed. This entry rate is in the 33% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 0.0% of appeals filed. This is in the 0% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 98% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 11% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 11% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.